These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 361054)
21. Comparison of clofibrate with halofenate in diabetics with hyperlipidaemia. Krut LH; Seftel HC; Joffe BI S Afr Med J; 1977 Mar; 51(11):348-52. PubMed ID: 323994 [TBL] [Abstract][Full Text] [Related]
22. Effect of clofibrate on progression of coronary disease: a prospective angiographic study in man. Cohn K; Sakai FJ; Langston MF Am Heart J; 1975 May; 89(5):591-8. PubMed ID: 1091127 [TBL] [Abstract][Full Text] [Related]
24. A cooperative trial on the primary prevention of ischaemic heart disease using clofibrate: design, methods, and progress. Heady JA Bull World Health Organ; 1973; 48(2):243-56. PubMed ID: 4578364 [TBL] [Abstract][Full Text] [Related]
25. Prevention of coronary heart disease--propaganda, promises, problems, and prospects. Oliver MF Circulation; 1986 Jan; 73(1):1-9. PubMed ID: 3510083 [No Abstract] [Full Text] [Related]
26. Clofibrate and the primary prevention of ischaemic heart disease. Br Med J; 1978 Dec; 2(6152):1585-6. PubMed ID: 728731 [No Abstract] [Full Text] [Related]
27. Clofibrate in coronary heart disease. Effect on morbidity and mortality. Krasno LR; Kidera GJ JAMA; 1972 Feb; 219(7):845-51. PubMed ID: 5066667 [No Abstract] [Full Text] [Related]
28. A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Miettinen M; Turpeinen O; Karvonen MJ Br Heart J; 1979 Sep; 42(3):370-1. PubMed ID: 508466 [No Abstract] [Full Text] [Related]
29. Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid. Carlson LA; Rosenhamer G Acta Med Scand; 1988; 223(5):405-18. PubMed ID: 3287837 [TBL] [Abstract][Full Text] [Related]
30. Serious adverse effects with clofibrate. N Z Med J; 1980 Oct; 92(670):315-6. PubMed ID: 6934431 [No Abstract] [Full Text] [Related]
31. [Treatment of primary hyperlipoproteinemias. Comparison of N 041 with clofibrate]. Gaertner U; Johannes KJ MMW Munch Med Wochenschr; 1976 Sep; 118(36):1127-30. PubMed ID: 184377 [TBL] [Abstract][Full Text] [Related]
32. Clinical trials with gugulipid. A new hypolipidaemic agent. Nityanand S; Srivastava JS; Asthana OP J Assoc Physicians India; 1989 May; 37(5):323-8. PubMed ID: 2693440 [TBL] [Abstract][Full Text] [Related]
33. Five-year trial of clofibrate in ischaemic heart disease. Dewar HA Br Heart J; 1971 Jan; 33(1):145. PubMed ID: 5541898 [No Abstract] [Full Text] [Related]
34. Primary prevention of coronary heart disease by lowering lipids: results and implications. Levy RI Am Heart J; 1985 Nov; 110(5):1116-22. PubMed ID: 3904377 [TBL] [Abstract][Full Text] [Related]
35. [3-year treatment of hypercholesteremia with clofibrate under conditions of double-blind method]. Metelitsa VI; Dokuchaeva EA; Chubukova AL; Iliushina IP; Ostrovskaia TP Ter Arkh; 1978; 50(1):45-50. PubMed ID: 345516 [No Abstract] [Full Text] [Related]
37. Effects of clofibrate in hyperlipidemia: a controlled trial. Ilyas M; Peracha MA; Ali N; Husnain Sherazi SM; Mahmood N J Pak Med Assoc; 1978 Sep; 28(9):126-8. PubMed ID: 105169 [No Abstract] [Full Text] [Related]
38. Ischemic heart disease: a secondary prevention trial using clofibrate (Atromid-S). Oliver MF Adv Exp Med Biol; 1972; 26(0):255-9. PubMed ID: 4679687 [No Abstract] [Full Text] [Related]
39. [Use of symfibrate in the treatment of hyperlipemias. Preliminary data]. Giuliani A; Trezzini C; Urbinati G; Conti R Clin Ter; 1979 Mar; 88(5):481-9. PubMed ID: 466970 [No Abstract] [Full Text] [Related]